New Strategies of ARV: the Road to Simplification.
de Miguel Buckley R, Montejano R, Stella-Ascariz N, Arribas JR.
Curr HIV/AIDS Rep. 2018
Jan 20.
Abstract
Brief Report: High Need to Switch cART or Comedication With the Initiation
of DAAs in Elderly HIV/HCV-Coinfected Patients.
Smolders EJ, Smit C, T M M de Kanter C,.ry
ak
J Acquir Immune Defic Syndr.
2017
Abstract
Quality of Life of HIV-infected Patients Who Switch
Antiretroviral Medication Due to Side Effects or Other Reasons.
Maiese EM, Johnson PT, Bancroft T,
et al
Curr Med Res Opin. 2016 Aug 23:1-24.
Abstract
Antiretroviral Treatment Switching and Its Association With Economic Outcomes
and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled
Patients With HIV in the United States.
Korsnes JS, Goodwin BB, Murray M, Candrilli SD.
Ann Pharmacother. 2016
Jul 20.
Abstract
Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure
that Cause Regimen Switching.
Kim MJ, Kim SW, Chang HH, et al
Infect Chemother. 2015
Dec;47(4):231-8.
Abstract
CD4+ and viral load outcomes of antiretroviral therapy switch
strategies after virologic failure of combination antiretroviral therapy in
perinatally HIV-infected youth in the United States.
Fairlie L, Karalius B, Patel K,
et al
AIDS. 2015 Jul 15
Abstract
The influence of patient beliefs and treatment satisfaction on
the discontinuation of current first-line antiretroviral regimens.
Casado JL, Marín A, Romero V, et al
HIV Med. 2015 Jul 6
Abstract
Successful antiretroviral therapy by using unusual
antiretroviral combinations in heavily pre-treated patients: two case
reports.
Taramasso L, Dentone C, Alessandrini A, et al
Int J STD AIDS.
2014 Oct 20.
Abstract
Improved virological and immunological efficacy of
resistance-guided switch in antiretroviral therapy: a Frankfurt HIV
cohort analysis.
Wolf T, Fuß B, Khaykin P, Berger A, et al
Med Microbiol Immunol.
2014 Aug 23
Abstract
Switch strategies in antiretroviral therapy regimens.
Van den Eynde E, Podzamczer D.
Expert Rev Anti Infect Ther.
2014 Jul 30:1.
Abstract
FULL-TEXT ARTICLE
High Level of Viral Suppression and Low Switch Rate to Second-Line
Antiretroviral Therapy among HIV-Infected
Adult Patients Followed over Five Years: Retrospective Analysis of the
DART Trial.
Kityo C, Gibb DM, Gilks CF, et al
PLoS One.
2014 Mar 13;9(3):e90772.
Paper
FULL=TEXT ARTICLE
Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load
Monitoring: A Randomized, Non-Inferiority Trial in Thailand.
Jourdain G, Le Cœur S, Ngo-Giang- et al
PLoS Med. 2013 Aug;10(8):e1001494.
Paper
Modeling clinical endpoints as a function of time of switch to
second-line ART with incomplete data on switching times.
Johnson BA, Ribaudo H, Gulick RM, Eron JJ Jr.
Biometrics.
2013 Jul 17.
Abstract
Efficacy of Antiretroviral Therapy Switch in
HIV-Infected
Patients: A 10-Year Analysis
of the EuResist Cohort. Oette M, Schülter E, Rosen-Zvi M, et al
Intervirology.
2012;55(2):160-6.
Abstract |